Department of Anesthesia and Intensive Care, Hospices Civils de Lyon, Femme Mère Enfant Hospital, Bron, Université Lyon 1, Lyon, France.
Service d'anesthésie réanimation, Groupement Hospitalier Est, Hospices Civils de Lyon, 59 Boulevard Pinel, 69500, Bron, France.
Can J Anaesth. 2024 Nov;71(11):1457-1465. doi: 10.1007/s12630-024-02852-9. Epub 2024 Oct 10.
The combination of acetaminophen with a nonsteroidal anti-inflammatory drug is the cornerstone of perioperative multimodal analgesia. These drugs can be administered intravenously or orally as premedication, consistent with the concept of pre-emptive and preventive analgesia. We aimed to assess the environmental impact of their intravenous and oral administration in a French university hospital.
We carried out a life cycle assessment to determine the amount of greenhouse gas emissions and depletion of water resources resulting from the oral vs intravenous administration of 1 g acetaminophen and 50 mg ketoprofen. We assessed two schemes of intravenous administration, depending on the use of the same or a different infusion set for each drug.
At our centre, the intravenous administration of both drugs was associated with the emission of 444-556 g CO equivalent (COe), and with 9.8-12.2 L of water waste. The oral administration of both drugs generated 8.36 g of COe emissions and consumed 1.16 L of water. At a national level, the switch from intravenous to oral premedication of the drugs could avoid the emission of 2,900-3,700 tons of COe and the waste of 58,000-74,000 m of water each year.
This eco-audit indicates that oral administration of acetaminophen and ketoprofen results in significantly lower carbon emissions and water consumption than intravenous administration. These findings highlight the importance of using the oral route for most patients, limiting intravenous administration for those with specific needs because of higher environmental impact and cost.
将对乙酰氨基酚与非甾体抗炎药联合使用是围手术期多模式镇痛的基石。这些药物可以作为术前用药静脉内或口服给药,符合预防性和预防镇痛的概念。我们旨在评估法国一所大学医院静脉内和口服给药的环境影响。
我们进行了生命周期评估,以确定口服与静脉内给予 1 g 对乙酰氨基酚和 50 mg 酮洛芬时温室气体排放和水资源消耗的差异。我们评估了两种静脉内给药方案,取决于每种药物使用相同或不同的输液套件。
在我们中心,两种药物的静脉内给药与 444-556 g 二氧化碳当量(COe)的排放和 9.8-12.2 L 的水浪费有关。两种药物的口服给药产生 8.36 g 的 COe 排放和 1.16 L 的水消耗。在全国范围内,将这些药物从静脉内给药转换为口服给药可避免每年排放 2900-3700 吨 COe 和浪费 58000-74000 m 的水。
这项生态审计表明,与静脉内给药相比,口服给予对乙酰氨基酚和酮洛芬可显著减少碳排放量和耗水量。这些发现强调了对于大多数患者使用口服途径的重要性,对于因环境影响和成本较高而有特定需求的患者,应限制静脉内给药。